Skip to main content
SpringerLink
Log in

Cancer-/Cancer Treatment-Related Salivary Gland Dysfunction

  • Chapter
  • First Online:
Dry Mouth

  • 2008 Accesses

Abstract

Salivary gland dysfunction (xerostomia, salivary gland hypofunction) is common in patients with cancer and is associated with significant morbidity/impairment of quality of life in this group of patients. This chapter will review the medical literature on the epidemiology, aetiology, clinical features and management of salivary gland dysfunction in patients with cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Uncommon causes.

  2. 2.

    Most common cause.

References

  1. Edgar WM, O’Mullane DM, editors. Saliva and oral health. 2nd ed. London: British Dental Association; 1996.

    Google Scholar 

  2. Navazesh M, Christensen C, Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res. 1992;71:1363–9.

    Article  PubMed  Google Scholar 

  3. Millard HD, Mason DK, editors. Perspectives on the 3rd world workshop on oral medicine. Ann Arbor: University of Michigan; 2000.

    Google Scholar 

  4. Davies A. Salivary gland dysfunction. In: Davies A, Finlay I, editors. Oral care in advanced disease. Oxford: Oxford University Press; 2005. p. 97–113.

    Chapter  Google Scholar 

  5. Billings RJ, Proskin HM, Moss ME. Xerostomia and associated factors in a community-dwelling adult population. Community Dent Oral Epidemiol. 1996;24:312–6.

    Article  PubMed  Google Scholar 

  6. Nederfors T, Isaksson R, Mornstad H, Dahlof C. Prevalence of perceived symptoms of dry mouth in an adult Swedish population – relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol. 1997;25:211–6.

    Article  PubMed  Google Scholar 

  7. Portenoy RK, Thaler HT, Kornblith AB, McCarthy Lepore JM, Friedlander-Klar H, et al. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res. 1994;3:183–9.

    Article  PubMed  Google Scholar 

  8. Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT. The Memorial Symptom Assessment Scale Short Form (MSAS-SF). Cancer. 2000;89:1162–71.

    Article  PubMed  Google Scholar 

  9. Davies AN, Broadley K, Beighton D. Xerostomia in patients with advanced cancer. J Pain Symptom Manag. 2001;22:820–5.

    Article  Google Scholar 

  10. Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the Memorial Symptom Assessment Scale. J Pain Symptom Manag. 2003;25:420–9.

    Article  Google Scholar 

  11. Shah S, Davies AN. Medical records vs. patient self-rating. J Pain Symptom Manag. 2001;22:805–6.

    Article  Google Scholar 

  12. Shorthose K, Davies A. Symptom prevalence in palliative care. Palliat Med. 2003;17:723–4.

    Article  PubMed  Google Scholar 

  13. Chaushu G, Bercovici M, Dori S, Waller A, Taicher S, Kronenberg J, et al. Salivary flow and its relation with oral symptoms in terminally ill patients. Cancer. 2000;88:984–7.

    Article  PubMed  Google Scholar 

  14. Davies AN, Broadley K, Beighton D. Salivary gland hypofunction in patients with advanced cancer. Oral Oncol. 2002;38:680–5.

    Article  PubMed  Google Scholar 

  15. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010;18:1039–60.

    Article  PubMed  Google Scholar 

  16. Anonymous. Saliva: its role in health and disease. FDI Working Group 10 of the Commission on Oral Health, Research and Epidemiology (CORE). Int Dent J. 1992;42(4 Suppl 2):291–304.

    Google Scholar 

  17. Sreebny LM, Valdini A, Yu A. Xerostomia. part II: relationship to nonoral symptoms, drugs, and diseases. Oral Surg Oral Med Oral Pathol. 1989;68:419–27.

    Article  PubMed  Google Scholar 

  18. Sreebny LM, Schwartz SS. A reference guide to drugs and dry mouth – 2nd edition. Gerodontology. 1997;14:33–47.

    Article  PubMed  Google Scholar 

  19. Smith RG, Burtner AP. Oral side-effects of the most frequently prescribed drugs. Spec Care Dentist. 1994;14:96–102.

    Article  PubMed  Google Scholar 

  20. Folli F, Ponzoni M, Vicari AM. Paraneoplastic autoimmune xerostomia. Ann Intern Med. 1997;127:167–8.

    Article  PubMed  Google Scholar 

  21. Schubert MM, Izutsu KT. Iatrogenic causes of salivary gland dysfunction. J Dent Res. 1987;66(Spec Iss):680–8.

    PubMed  Google Scholar 

  22. Solans R, Bosch JA, Galofre P, Porta F, Rosello J, Seva-O’Callagan A, et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med. 2001;42:738–43.

    PubMed  Google Scholar 

  23. Nagler RM, Gez E, Rubinov R, Laufer D, Ben-Aryeh H, Gaitini D, et al. The effect of low-dose interleukin-2-based immunotherapy on salivary function and composition in patients with metastatic renal cell carcinoma. Arch Oral Biol. 2001;46:487–93.

    Article  PubMed  Google Scholar 

  24. Nagler R, Marmary Y, Krausz Y, Chisin R, Markitziu A, Nagler A. Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD). Bone Marrow Transplant. 1996;17:219–24.

    PubMed  Google Scholar 

  25. Gregersen MI, Bullock LT. Observations on thirst in man in relation to changes in salivary flow and plasma volume. Am J Physiol. 1933;105:39–40.

    Google Scholar 

  26. Johansson I, Ericson T. Effects of a 900-kcal liquid or solid diet on saliva flow rate and composition in female subjects. Caries Res. 1989;23:184–9.

    Article  PubMed  Google Scholar 

  27. Bergdahl M, Bergdahl J. Low unstimulated salivary flow and subjective oral dryness: association with medication, anxiety, depression, and stress. J Dent Res. 2000;79:1652–8.

    Article  PubMed  Google Scholar 

  28. Antilla SS, Knuuttila ML, Sakki TK. Depressive symptoms as an underlying factor of the sensation of dry mouth. Psychosom Med. 1998;60:215–8.

    Article  Google Scholar 

  29. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res. 1987;66(Spec):648–53.

    PubMed  Google Scholar 

  30. Pankhurst CL, Smith EC, Rogers JO, Dunne SM, Jackson SHD, Proctor G. Diagnosis and management of the dry mouth: part 1. Dent Update. 1996;23:56–62.

    PubMed  Google Scholar 

  31. Davies A. Salivary gland dysfunction. In: Davies AN, Epstein JB, editors. Oral complications of cancer and its management. Oxford: Oxford University Press; 2010. p. 203–23.

    Chapter  Google Scholar 

  32. Rydholm M, Strang P. Physical and psychosocial impact of xerostomia in palliative cancer care: a qualitative interview study. Int J Palliat Nurs. 2002;8:318–23.

    Article  PubMed  Google Scholar 

  33. National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE). Available from National Cancer Institute (US National Institutes of Health) website: http://www.cancer.gov/.

  34. Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C, Eisbruch A. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;66:445–53.

    Article  PubMed  Google Scholar 

  35. Jha N, Seikaly H, Harris J, Williams D, Liu R, McGaw T, et al. Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol. 2003;66:283–9.

    Article  PubMed  Google Scholar 

  36. Sasse AD, Clark LG, Sasse EC, Clark OA. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis. Int J Radiat Oncol Biol Phys. 2006;64:784–91.

    Article  PubMed  Google Scholar 

  37. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer. 2010;18:1061–79.

    Article  PubMed  Google Scholar 

  38. Atkinson JC, Baum BJ. Salivary enhancement: current status and future therapies. J Dent Educ. 2001;65:1096–101.

    PubMed  Google Scholar 

  39. Bjornstrom M, Axell T, Birkhed D. Comparison between saliva stimulants and saliva substitutes in patients with symptoms related to dry mouth. A multi-centre study. Swed Dent J. 1990;14:153–61.

    PubMed  Google Scholar 

  40. Stewart CM, Jones AC, Bates RE, Sandow P, Pink F, Stillwell J. Comparison between saliva stimulants and a saliva substitute in patients with xerostomia and hyposalivation. Spec Care Dentist. 1998;18:142–8.

    Article  PubMed  Google Scholar 

  41. Abelson DC, Barton J, Mandel ID. Effect of sorbitol sweetened breath mints on salivary flow and plaque pH in xerostomic subjects. J Clin Dent. 1989;1:102–5.

    PubMed  Google Scholar 

  42. Davies AN. A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliat Med. 2000;14:197–203.

    Article  PubMed  Google Scholar 

  43. Aagaard A, Godiksen S, Teglers PT, Schiodt M, Glenert U. Comparison between new saliva stimulants in patients with dry mouth: a placebo-controlled double-blind crossover study. J Oral Pathol Med. 1992;21:376–80.

    Article  PubMed  Google Scholar 

  44. Newbrun E. Xerostomia. Oral Surg Oral Med Oral Pathol. 1981;52:262.

    PubMed  Google Scholar 

  45. Davies AN, Daniels C, Pugh R, Sharma K. A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer. Palliat Med. 1998;12:105–11.

    Article  PubMed  Google Scholar 

  46. Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, Ng D, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med. 1993;329:390–5.

    Article  PubMed  Google Scholar 

  47. LeVeque FG, Montgomery M, Potter D, Zimmer MB, Rieke JW, Steiger BW, et al. A multicentre, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol. 1993;11:1124–31.

    PubMed  Google Scholar 

  48. Singhal S, Mehta J, Rattenbury H, Treleaven J, Powles R. Oral pilocarpine hydrochloride for the treatment of refractory xerostomia associated with chronic graft-versus-host disease. Blood. 1995;85:1147–8.

    PubMed  Google Scholar 

  49. Nagler RM, Nagler A. Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study. Bone Marrow Transplant. 1999;23:1007–11.

    Article  PubMed  Google Scholar 

  50. Davies AN, Singer J. A comparison of artificial saliva and pilocarpine in radiation-induced xerostomia. J Laryngol Otol. 1994;108:663–5.

    Article  PubMed  Google Scholar 

  51. Davies AN, Shorthose K. Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy. Cochrane Database Syst Rev. 2007;(3):CD003782.

    Google Scholar 

  52. Everett HC. The use of bethanechol chloride with tricyclic antidepressants. Am J Psychiatry. 1975;132:1202–4.

    PubMed  Google Scholar 

  53. Epstein JB, Burchell JL, Emerton S, Le ND, Silverman Jr S. A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study. Oral Surg Oral Med Oral Pathol. 1994;77:610–4.

    Article  PubMed  Google Scholar 

  54. Gorsky M, Epstein JB, Parry J, Epstein MS, Le ND, Silverman Jr S. The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97:190–5.

    Article  PubMed  Google Scholar 

  55. Chambers MS, Posner M, Jones CU, Biel MA, Hodge KM, Vitti R, et al. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;68:1102–9.

    Article  PubMed  Google Scholar 

  56. Witsell DL, Stinnett S, Chambers MS. Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia. Head Neck. 2012;34:1136–42.

    Article  PubMed  Google Scholar 

  57. Carpenter PA, Schubert MM, Flowers ME. Cevimeline reduced mouth dryness and increased salivary flow in patients with xerostomia complicating chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2006;12:792–4.

    Article  PubMed  Google Scholar 

  58. Rydholm M, Strang P. Acupuncture for patients in hospital-based home care suffering from xerostomia. J Palliat Care. 1999;15:20–3.

    PubMed  Google Scholar 

  59. Blom M, Dawidson I, Fernberg JO, Johnson G, Angmar-Mansson B. Acupuncture treatment of patients with radiation-induced xerostomia. Eur J Cancer B Oral Oncol. 1996;32B:182–90.

    Article  PubMed  Google Scholar 

  60. Simcock R, Fallowfield L, Monson K, Solis-Trapala I, Parlour L, Langridge C, et al. ARIX: a randomised trial of acupuncture v oral care sessions in patients with chronic xerostomia following treatment of head and neck cancer. Ann Oncol. 2013;24:776–83.

    Article  PubMed  Google Scholar 

  61. Meng Z, Garcia MK, Hu C, Chiang J, Chambers M, Rosenthal DI, et al. Randomized controlled trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma. Cancer. 2012;118:3337–44.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Johnstone PA, Niemtzow RC, Riffenburgh RH. Acupuncture for xerostomia: clinical update. Cancer. 2002;94:1151–6.

    Article  PubMed  Google Scholar 

  63. Duxbury AJ, Thakker NS, Wastell DG. A double-blind cross-over trial of a mucin-containing artificial saliva. Br Dent J. 1989;166:115–20.

    Article  PubMed  Google Scholar 

  64. Wiesenfeld D, Stewart AM, Mason DK. A critical assessment of oral lubricants in patients with xerostomia. Br Dent J. 1983;155:155–7.

    Article  PubMed  Google Scholar 

  65. Olsson H, Axell T. Objective and subjective efficacy of saliva substitutes containing mucin and carboxymethylcellulose. Scand J Dent Res. 1991;99:316–9.

    PubMed  Google Scholar 

  66. Epstein JB, Stevenson-Moore P. A clinical comparative trial of saliva substitutes in radiation-induced salivary gland hypofunction. Spec Care Dentist. 1992;12:21–3.

    Article  PubMed  Google Scholar 

  67. Vissink A, ‘s-Gravenmade EJ, Panders AK, Vermey A, Petersen JK, Visch LL, et al. A clinical comparison between commercially available mucin- and CMC-containing saliva substitutes. Int J Oral Surg. 1983;12:232–8.

    Article  PubMed  Google Scholar 

  68. Visch LL, ‘s-Gravenmade EJ, Schaub RM, Van Putten WL, Vissink A. A double-blind crossover trial of CMC- and mucin-containing saliva substitutes. Int J Oral Maxillofac Surg. 1986;15:395–400.

    Article  PubMed  Google Scholar 

  69. Epstein JB, Emerton S, Le ND, Stevenson-Moore P. A double-blind crossover trial of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol. 1999;35:132–7.

    Article  PubMed  Google Scholar 

  70. Shahdad SA, Taylor C, Barclay SC, Steen IN, Preshaw PM. A double-blind, crossover study of Biotene Oralbalance and BioXtra systems as salivary substitutes in patients with post-radiotherapy xerostomia. Eur J Cancer Care. 2005;14:319–26.

    Article  Google Scholar 

  71. Tenovuo J. Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety. Oral Dis. 2002;8:23–9.

    Article  PubMed  Google Scholar 

  72. Andersson G, Johansson G, Attstrom R, Edwardsson S, Glantz PO, Larsson K. Comparison of the effect of the linseed extract Salinum and a methyl cellulose preparation on the symptoms of dry mouth. Gerodontology. 1995;12:12–7.

    Article  PubMed  Google Scholar 

  73. Rhodus NL, Bereuter J. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjogren’s syndrome. J Otolaryngol. 2000;29:28–34.

    PubMed  Google Scholar 

  74. Sweeney P. Oral hygiene. In: Davies A, Finlay I, editors. Oral care in advanced disease. Oxford: Oxford University Press; 2005. p. 21–35.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Supportive & Palliative Care Team, Royal Surrey County Hospital, Egerton Road, Guildford, Surrey, GU2 7XX, UK

    Andrew N. Davies FRCP

Authors
  1. Andrew N. Davies FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew N. Davies FRCP .

Editor information

Editors and Affiliations

  1. Department of Salivary Research, Kings College London Dental Institute, London, United Kingdom

    Guy Carpenter

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Davies, A.N. (2015). Cancer-/Cancer Treatment-Related Salivary Gland Dysfunction. In: Carpenter, G. (eds) Dry Mouth. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55154-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55154-3_4

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-55153-6

  • Online ISBN: 978-3-642-55154-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation